Project Number 5U01AG046170-09 Agency/Funding Organization NIA Funding Year 2021 View Full Project Details for Integrative Network Biology Approaches to Identify, Characterize and Validate Molecular Subtypes in Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 2. Identification and Validation of Novel Targets Category G. Consortia and Public Private Partnerships 2. Public Private Partnership Researcher and Organization Principal Investigator ZHANG, BIN Principal Investigator First Name MICHELLE Principal Investigator Last Name EHRLICH Awardee Organization ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI Awardee State New York, N.Y. Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-18-013: Continuation of the AMP-AD Target Discovery and Preclinical Validation Consortium (U01 Clinical Trial Optional) FY Overall Cost $1,848,040 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PETANCESKA, SUZANA Special Initiative Accelerating Medicines Partnership - Alzheimer's Disease (AMP-AD): Target Discovery and Preclinical Validation Project Related Resources Repository [AMP-AD Knowledge Portal] Integrative Biology Approach to Complexity of Alzheimer’s Disease
